Assembly Biosciences, Inc

Tricida, based in South San Francisco, CA, is a company that provides information on SEC.gov. With a focus on delivering comprehensive information, Tricida offers valuable insights and resources through its platform.Generated from the website

IDEAYA Biosciences, Inc is a clinical-stage precision medicine oncology company headquartered in South San Francisco, California. They are dedicated to the discovery and development of targeted therapeutics for cancer patients using molecular diagnostics. With a focus on synthetic lethality, an emerging class of precision medicine targets, IDEAYA aims to deliver first-in-class and best-in-class therapeutics that have the potential to transform patient outcomes. IDEAYA was founded on the belief that attracting top scientists and focusing on transformative research is key to developing game-changing medicines. Their integrated approach combines biomarker and target discovery with the development of small molecule and protein degrader therapeutics, from early discovery through clinical development. By leveraging the concept of synthetic lethality, IDEAYA seeks to inhibit target proteins in patient populations selected based on genetic alterations, addressing unmet needs in cancer treatment.Generated from the website

Kezar Life Sciences, Inc. is a biopharmaceutical company based in South San Francisco, CA, dedicated to developing innovative protein-targeting approaches for the treatment of chronic diseases. With a focus on regulating cellular function, Kezar is advancing novel, first-in-class small molecule therapies that selectively inhibit specific proteins involved in disease activation. By targeting multiple drivers of disease, their unique approaches have the potential to provide broad treatment effects across a range of chronic conditions. Kezar's pipeline includes Zetomipzomib (KZR-616), a selective immunoproteasome inhibitor aimed at modulating the immune system to treat autoimmune diseases, and KZR-261, a protein secretion inhibitor designed to halt the proliferation of diseases in oncology and autoimmunity. Committed to improving patient outcomes, Kezar is actively seeking collaborative and innovative individuals to join their team in developing breakthrough treatments for autoimmune diseases and cancer.Generated from the website